Financials

  • Market Capitalization 169.57 M
  • Employee 134
  • Founded 2004
  • CEO N/A
  • Website www.molecularpartners.com
  • Headquarter Switzerland
  • FIGI BBG010B7DHZ0
  • Industry Technology

Molecular Partners AG - American Depositary Shares

Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins, with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and infectious diseases. Molecular Partners currently has two DARPin molecules in clinical development, and a broad pipeline of molecules in preclinical development.

Notícias